Export Ready — 

Anti-SARS-CoV-2 Seroconversion in COVID-19 Convalescent Kidney Transplant Recipients Compared with Non-transplanted Patients

Bibliographic Details
Main Author: Garcia, Ricardo Martins
Publication Date: 2023
Other Authors: Gomes, Vinicius Lafico Teixeira, Foresto, Renato Demarchi, Nakamura, Mônica Rika, Jesus, Marcia Araújo Toffoli de, Lucena, Elisabeth França, Rissoni, Renata Pimentel, Cristelli, Marina Pontello, Silva Junior, Helio Tedesco, Requião-Moura, Lúcio, Pestana, José Medina
Format: Article
Language: eng
por
Source: Brazilian Journal of Transplantation
Download full: https://bjt.emnuvens.com.br/revista/article/view/518
Summary: Objective: Due to immunosuppression, kidney transplant recipients (KTRs) might have lower seroconversion after COVID-19 than non-KTRs. Thus, we aimed to evaluate the seroconversion rate after COVID-19 between KTRs and non- KTRs. Methods: This cohort study enrolled three non-paired groups of patients with COVID-19: 601 KTRs, 211 healthcare workers (HCWs), and 170 non-transplanted inhabitants (INHs) in a countryside city in Brazil. The anti-severe acute respiratory syndrome coronavirus 2 nucleocapsid antibody was assessed 14 days after diagnosis. The primary outcome was seroconversion. Results: The KTRs were older, had more comorbidities and severe COVID-19. Compared to HCWs and INHs, admission to the intensive care unit (ICU; 44.9% vs. 0% vs. 1.8%, p<0.001), mechanical ventilation requirement (32.3% vs. 0% vs. 1.8%, p<0.001), and death (28.8% vs. 0% vs. 1.2%, p<0.001) were significantly higher in KTRs. Seroconversion did not differ between the groups: 76.2% in KTRs, 74.9% in HCWs, and 82.2% in INHs (p=0.35). In a group-adjusted multivariable logistic regression, while a short period between infection and blood sample collection reduced the probability of seroconversion (adjusted odds ratio [aOR]=0.986), the presence of fever (aOR=1.737, p=0.017), cough (aOR=1.785, p=0.005), and requirement for ventilatory support (OR=1.981, p=0.017) increased the risk. Conclusions: Clinical severity, mechanical ventilation requirement and death by COVID-19 were significantly higher among the KTRs. However, amongthe survivors, KTRs had a similar seroconversion prevalence associated with clinical severity parameters and a shorter time of blood sample collection.
id ABTO_040c4acf947cdff7ecc6e00fe2b44a43
oai_identifier_str oai:ojs3.emnuvens.com.br:article/518
network_acronym_str ABTO
network_name_str Brazilian Journal of Transplantation
repository_id_str
spelling Anti-SARS-CoV-2 Seroconversion in COVID-19 Convalescent Kidney Transplant Recipients Compared with Non-transplanted PatientsSoroconversão de Anticorpos Anti-SARS-CoV-2 em Receptores de Transplante Renal Convalescentes com COVID-19 em Comparação com Pacientes Não TransplantadosCOVID-19COVID-19SARS-CoV-2Kidney Transplant RecipientsSeroconversionseroconversionObjective: Due to immunosuppression, kidney transplant recipients (KTRs) might have lower seroconversion after COVID-19 than non-KTRs. Thus, we aimed to evaluate the seroconversion rate after COVID-19 between KTRs and non- KTRs. Methods: This cohort study enrolled three non-paired groups of patients with COVID-19: 601 KTRs, 211 healthcare workers (HCWs), and 170 non-transplanted inhabitants (INHs) in a countryside city in Brazil. The anti-severe acute respiratory syndrome coronavirus 2 nucleocapsid antibody was assessed 14 days after diagnosis. The primary outcome was seroconversion. Results: The KTRs were older, had more comorbidities and severe COVID-19. Compared to HCWs and INHs, admission to the intensive care unit (ICU; 44.9% vs. 0% vs. 1.8%, p<0.001), mechanical ventilation requirement (32.3% vs. 0% vs. 1.8%, p<0.001), and death (28.8% vs. 0% vs. 1.2%, p<0.001) were significantly higher in KTRs. Seroconversion did not differ between the groups: 76.2% in KTRs, 74.9% in HCWs, and 82.2% in INHs (p=0.35). In a group-adjusted multivariable logistic regression, while a short period between infection and blood sample collection reduced the probability of seroconversion (adjusted odds ratio [aOR]=0.986), the presence of fever (aOR=1.737, p=0.017), cough (aOR=1.785, p=0.005), and requirement for ventilatory support (OR=1.981, p=0.017) increased the risk. Conclusions: Clinical severity, mechanical ventilation requirement and death by COVID-19 were significantly higher among the KTRs. However, amongthe survivors, KTRs had a similar seroconversion prevalence associated with clinical severity parameters and a shorter time of blood sample collection.Objetivo: Devido à imunossupressão, receptores de transplante renal (RTRs) podem ter menor soroconversão após COVID-19 do que indivíduos não-transplantados. Assim, nosso objetivo foi avaliar a taxa de soroconversão após COVID-19 entre RTRs e não-RTRs. Métodos: Este estudo de coorte envolveu três grupos não pareados de pacientes com COVID-19: 601 RTRs, 211 profissionais de saúde (PSs) e 170 habitantes não transplantados (HNTs) em uma cidade do interior do Brasil. O anticorpo anti- SARS-CoV-2 foi avaliado 14 dias após o diagnóstico. O desfecho primário foi a taxa de soroconversão. Resultados: Os RTRs eram mais idosos, com mais comorbidades e COVID-19 grave. Em comparação com profissionais de saúde e HNTs, admissão na unidade de terapia intensiva (UTI; 44,9% vs. 0% vs. 1,8%, p<0,001), necessidade de ventilação mecânica (32,3% vs. 0% vs. 1,8%, p<0,001), e óbito (28,8% vs. 0% vs. 1,2%, p<0,001) foram significativamente maiores em RTRs. A soroconversão não diferiu entre os grupos: 76,2% em RTRs, 74,9% em PSs e 82,2% em HNTs (p=0,35). Em uma regressão logística multivariada ajustada ao grupo, enquanto um curto período entre a infecção e a coleta da amostra de sangue reduziu a probabilidade de soroconversão (odds ratio [aOR] = 0,986), a presença de febre (aOR = 1,737, p = 0,017), tosse (aOR=1,785, p=0,005) e necessidade de suporte ventilatório(OR=1,981, p=0,017) aumentaram o risco. Conclusões: A gravidade clínica, a necessidade de ventilação mecânica e a morte por COVID-19 foram significativamente maiores entre os RTRs. No entanto, entre os sobreviventes, os RTRs tiveram prevalência de soroconversão semelhante associada aos parâmetros de gravidade clínica e menor tempo de coleta de amostra de sangue.Associação Brasileira de Transplante de Órgãos (ABTO)2023-07-31info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdfapplication/pdfhttps://bjt.emnuvens.com.br/revista/article/view/518Brazilian Journal of Transplantation; Vol. 26 (2023)Brazilian Journal of Transplantation; v. 26 (2023)2764-1589reponame:Brazilian Journal of Transplantationinstname:Associação Brasileira de Transplante de Órgãos (ABTO)instacron:ABTOengporhttps://bjt.emnuvens.com.br/revista/article/view/518/570https://bjt.emnuvens.com.br/revista/article/view/518/571Copyright (c) 2023 Ricardo Martins Garcia, Vinicius Lafico Teixeira Gomes, Renato Demarchi Foresto, Mônica Rika Nakamura, Marcia Araújo Toffoli de Jesus, Elisabeth França Lucena, Renata Pimentel Rissoni, Marina Pontello Cristelli, Helio Tedesco Silva Junior, Lúcio Requião-Moura, José Medina Pestanainfo:eu-repo/semantics/openAccessGarcia, Ricardo Martins Gomes, Vinicius Lafico TeixeiraForesto, Renato Demarchi Nakamura, Mônica RikaJesus, Marcia Araújo Toffoli deLucena, Elisabeth FrançaRissoni, Renata PimentelCristelli, Marina PontelloSilva Junior, Helio TedescoRequião-Moura, LúcioPestana, José Medina 2023-12-27T11:59:05Zoai:ojs3.emnuvens.com.br:article/518Revistahttps://bjt.emnuvens.com.br/revistaONGhttps://bjt.emnuvens.com.br/revista/oaibjt@abto.org.brhttps://doi.org/10.53855/2764-15892764-1589opendoar:2023-12-27T11:59:05Brazilian Journal of Transplantation - Associação Brasileira de Transplante de Órgãos (ABTO)false
dc.title.none.fl_str_mv Anti-SARS-CoV-2 Seroconversion in COVID-19 Convalescent Kidney Transplant Recipients Compared with Non-transplanted Patients
Soroconversão de Anticorpos Anti-SARS-CoV-2 em Receptores de Transplante Renal Convalescentes com COVID-19 em Comparação com Pacientes Não Transplantados
title Anti-SARS-CoV-2 Seroconversion in COVID-19 Convalescent Kidney Transplant Recipients Compared with Non-transplanted Patients
spellingShingle Anti-SARS-CoV-2 Seroconversion in COVID-19 Convalescent Kidney Transplant Recipients Compared with Non-transplanted Patients
Garcia, Ricardo Martins
COVID-19
COVID-19
SARS-CoV-2
Kidney Transplant Recipients
Seroconversion
seroconversion
title_short Anti-SARS-CoV-2 Seroconversion in COVID-19 Convalescent Kidney Transplant Recipients Compared with Non-transplanted Patients
title_full Anti-SARS-CoV-2 Seroconversion in COVID-19 Convalescent Kidney Transplant Recipients Compared with Non-transplanted Patients
title_fullStr Anti-SARS-CoV-2 Seroconversion in COVID-19 Convalescent Kidney Transplant Recipients Compared with Non-transplanted Patients
title_full_unstemmed Anti-SARS-CoV-2 Seroconversion in COVID-19 Convalescent Kidney Transplant Recipients Compared with Non-transplanted Patients
title_sort Anti-SARS-CoV-2 Seroconversion in COVID-19 Convalescent Kidney Transplant Recipients Compared with Non-transplanted Patients
author Garcia, Ricardo Martins
author_facet Garcia, Ricardo Martins
Gomes, Vinicius Lafico Teixeira
Foresto, Renato Demarchi
Nakamura, Mônica Rika
Jesus, Marcia Araújo Toffoli de
Lucena, Elisabeth França
Rissoni, Renata Pimentel
Cristelli, Marina Pontello
Silva Junior, Helio Tedesco
Requião-Moura, Lúcio
Pestana, José Medina
author_role author
author2 Gomes, Vinicius Lafico Teixeira
Foresto, Renato Demarchi
Nakamura, Mônica Rika
Jesus, Marcia Araújo Toffoli de
Lucena, Elisabeth França
Rissoni, Renata Pimentel
Cristelli, Marina Pontello
Silva Junior, Helio Tedesco
Requião-Moura, Lúcio
Pestana, José Medina
author2_role author
author
author
author
author
author
author
author
author
author
dc.contributor.author.fl_str_mv Garcia, Ricardo Martins
Gomes, Vinicius Lafico Teixeira
Foresto, Renato Demarchi
Nakamura, Mônica Rika
Jesus, Marcia Araújo Toffoli de
Lucena, Elisabeth França
Rissoni, Renata Pimentel
Cristelli, Marina Pontello
Silva Junior, Helio Tedesco
Requião-Moura, Lúcio
Pestana, José Medina
dc.subject.por.fl_str_mv COVID-19
COVID-19
SARS-CoV-2
Kidney Transplant Recipients
Seroconversion
seroconversion
topic COVID-19
COVID-19
SARS-CoV-2
Kidney Transplant Recipients
Seroconversion
seroconversion
description Objective: Due to immunosuppression, kidney transplant recipients (KTRs) might have lower seroconversion after COVID-19 than non-KTRs. Thus, we aimed to evaluate the seroconversion rate after COVID-19 between KTRs and non- KTRs. Methods: This cohort study enrolled three non-paired groups of patients with COVID-19: 601 KTRs, 211 healthcare workers (HCWs), and 170 non-transplanted inhabitants (INHs) in a countryside city in Brazil. The anti-severe acute respiratory syndrome coronavirus 2 nucleocapsid antibody was assessed 14 days after diagnosis. The primary outcome was seroconversion. Results: The KTRs were older, had more comorbidities and severe COVID-19. Compared to HCWs and INHs, admission to the intensive care unit (ICU; 44.9% vs. 0% vs. 1.8%, p<0.001), mechanical ventilation requirement (32.3% vs. 0% vs. 1.8%, p<0.001), and death (28.8% vs. 0% vs. 1.2%, p<0.001) were significantly higher in KTRs. Seroconversion did not differ between the groups: 76.2% in KTRs, 74.9% in HCWs, and 82.2% in INHs (p=0.35). In a group-adjusted multivariable logistic regression, while a short period between infection and blood sample collection reduced the probability of seroconversion (adjusted odds ratio [aOR]=0.986), the presence of fever (aOR=1.737, p=0.017), cough (aOR=1.785, p=0.005), and requirement for ventilatory support (OR=1.981, p=0.017) increased the risk. Conclusions: Clinical severity, mechanical ventilation requirement and death by COVID-19 were significantly higher among the KTRs. However, amongthe survivors, KTRs had a similar seroconversion prevalence associated with clinical severity parameters and a shorter time of blood sample collection.
publishDate 2023
dc.date.none.fl_str_mv 2023-07-31
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv https://bjt.emnuvens.com.br/revista/article/view/518
url https://bjt.emnuvens.com.br/revista/article/view/518
dc.language.iso.fl_str_mv eng
por
language eng
por
dc.relation.none.fl_str_mv https://bjt.emnuvens.com.br/revista/article/view/518/570
https://bjt.emnuvens.com.br/revista/article/view/518/571
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
application/pdf
dc.publisher.none.fl_str_mv Associação Brasileira de Transplante de Órgãos (ABTO)
publisher.none.fl_str_mv Associação Brasileira de Transplante de Órgãos (ABTO)
dc.source.none.fl_str_mv Brazilian Journal of Transplantation; Vol. 26 (2023)
Brazilian Journal of Transplantation; v. 26 (2023)
2764-1589
reponame:Brazilian Journal of Transplantation
instname:Associação Brasileira de Transplante de Órgãos (ABTO)
instacron:ABTO
instname_str Associação Brasileira de Transplante de Órgãos (ABTO)
instacron_str ABTO
institution ABTO
reponame_str Brazilian Journal of Transplantation
collection Brazilian Journal of Transplantation
repository.name.fl_str_mv Brazilian Journal of Transplantation - Associação Brasileira de Transplante de Órgãos (ABTO)
repository.mail.fl_str_mv bjt@abto.org.br
_version_ 1836111235283681280